Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Related Articles by Review for PubMed (Select 23657947)

1.

The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.

Zhang F, Xiang H, Fan Y, Ganchuluun TA, Kong W, Ouyang Q, Sun J, Cao B, Jiang H, Nie S.

Endocrine. 2013 Dec;44(3):648-58. doi: 10.1007/s12020-013-9970-6. Epub 2013 May 9.

PMID:
23657947
2.

Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.

Thakkar B, Aronis KN, Vamvini MT, Shields K, Mantzoros CS.

Metabolism. 2013 Jul;62(7):922-34. doi: 10.1016/j.metabol.2013.01.014. Epub 2013 Feb 16. Review.

PMID:
23419783
3.

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.

Cochrane Database Syst Rev. 2013 Apr 30;4:CD009008. doi: 10.1002/14651858.CD009008.pub2. Review.

PMID:
23633364
4.

Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis.

Hirst JA, Farmer AJ, Dyar A, Lung TW, Stevens RJ.

Diabetologia. 2013 May;56(5):973-84. doi: 10.1007/s00125-013-2856-6. Epub 2013 Mar 15. Review.

5.

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.

Wulffelé MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT.

J Intern Med. 2004 Jul;256(1):1-14. Review.

PMID:
15189360
6.

Metformin: an antihyperglycemic agent for treatment of type II diabetes.

Melchior WR, Jaber LA.

Ann Pharmacother. 1996 Feb;30(2):158-64. Review.

PMID:
8835050
7.

Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.

Liu SC, Tu YK, Chien MN, Chien KL.

Diabetes Obes Metab. 2012 Sep;14(9):810-20. doi: 10.1111/j.1463-1326.2012.01606.x. Epub 2012 Apr 29. Review.

PMID:
22486990
8.

Treatment of non-insulin-dependent diabetes mellitus with metformin.

Guthrie R.

J Am Board Fam Pract. 1997 May-Jun;10(3):213-21. Review.

PMID:
9159660
9.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
10.

Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas - a meta-analysis from randomized clinical trials.

Zhang Y, Hong J, Chi J, Gu W, Ning G, Wang W.

Diabetes Metab Res Rev. 2014 Mar;30(3):241-56. doi: 10.1002/dmrr.2482. Review.

PMID:
24123720
11.

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.

Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, Marinopoulos SS, Puhan MA, Ranasinghe P, Block L, Nicholson WK, Hutfless S, Bass EB, Bolen S.

Ann Intern Med. 2011 May 3;154(9):602-13. doi: 10.7326/0003-4819-154-9-201105030-00336. Epub 2011 Mar 14. Review. Erratum in: Ann Intern Med. 2011 Jul 5;155(1):67-8.

12.
13.

An overview of metformin in the treatment of type 2 diabetes mellitus.

Davidson MB, Peters AL.

Am J Med. 1997 Jan;102(1):99-110. Review.

PMID:
9209206
14.

Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.

Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL.

Ann Intern Med. 2007 Sep 18;147(6):386-99. Epub 2007 Jul 16. Review. Erratum in: Ann Intern Med. 2007 Dec 18;147(12):887.

PMID:
17638715
15.

Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.

Monami M, Vitale V, Ambrosio ML, Bartoli N, Toffanello G, Ragghianti B, Monami F, Marchionni N, Mannucci E.

Adv Ther. 2012 Sep;29(9):736-46. doi: 10.1007/s12325-012-0045-5. Epub 2012 Aug 24. Review.

PMID:
22923161
16.

Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.

Goo AK, Carson DS, Bjelajac A.

J Fam Pract. 1996 Jun;42(6):612-8. Review.

PMID:
8656173
17.

Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.

Setter SM, Iltz JL, Thams J, Campbell RK.

Clin Ther. 2003 Dec;25(12):2991-3026. Review.

PMID:
14749143
18.

Interventions for latent autoimmune diabetes (LADA) in adults.

Brophy S, Davies H, Mannan S, Brunt H, Williams R.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD006165. doi: 10.1002/14651858.CD006165.pub3. Review.

PMID:
21901702
19.

[Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus].

Valerón PF, de Pablos-Velasco PL.

Med Clin (Barc). 2013 Sep;141 Suppl 2:20-5. doi: 10.1016/S0025-7753(13)70059-9. Review. Spanish.

PMID:
24444520
20.

Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses.

Hemmingsen B, Christensen LL, Wetterslev J, Vaag A, Gluud C, Lund SS, Almdal T.

BMJ. 2012 Apr 19;344:e1771. doi: 10.1136/bmj.e1771. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk